Stay informed with the January ORWH Pulse

National Institutes of Health - Office of Research on Women's Health sent this bulletin at 01/31/2023 04:20 PM EST

Having trouble viewing this email? View it as a Web page.

January 2023

Building on Our Accomplishments in 2022 to Continue Promoting Women’s Health in 2023

Throughout 2022, ORWH and its partners continued to rally to advance the health of women and careers of women in biomedical fields. Although there were some notable challenges along the way, I am proud of what we accomplished and look forward to building on the momentum gained last year. I would like to thank all ORWH staff members, our NIH colleagues, and all our partners beyond NIH for their tireless efforts and dedication to improving the health of women.

Learn More

ORWH Launched New Webpage on Sex and Gender

ORWH recently launched the What are Sex & Gender? webpage, which expands the definitions of sex and gender, their differences and interactions, how they affect health, and why they are important in health research. The study of how sex and gender influence health and disease is central to the NIH mission of enhancing health, lengthening life, and reducing illness for all people. Together, with others in the NIH community, ORWH is committed to setting the example across scientific research that consideration of sex and gender is critical for rigorous and responsible science and for establishing a future in which every person can receive safe, effective, evidence-based medical care.

Learn More

What are Sex & Gender webpage screenshot image

New Issue of In Focus Explores
Disparities and Workforce Diversity in Mental Health

Women's Health in Focus at NIH volume 6 issue 1 cover

The latest issue of Women’s Health in Focus at NIH explores disparities and workforce diversity in mental health. The feature story discusses mental health disparities, the lack of diversity in the mental health workforce, and Federal initiatives addressing these issues. A guest editorial by Rita Valentino, Ph.D., Director of the Division of Neuroscience and Behavior at the National Institute on Drug Abuse (NIDA), discusses NIH support of research to promote a greater understanding of sex differences in substance use disorder (SUDs) and the treatment of SUDs.

Learn More

Read In the Spotlight Articles

Opportunities and announcements - revised

Featured Announcements

Notice of Special Interest (NOSI): Research on Gender Measurement (Admin Supp Clinical Trial Optional)
(NOT-OD-23-046)
First available due date: February 28, 2023

These administrative supplements will support research testing of gender-related terminology used in measuring current gender identity as part of a two-step method of data collection (sex assigned at birth and current gender identity).

This opportunity is co-funded by the Office of Research on Women’s Health in partnership with the National Institute on Aging, the National Institute of Allergy and Infectious Diseases, the National Institute on Drug Abuse, the National Institute on Minority Health and Health Disparities, the National Library of Medicine, the National Cancer Institute, and the Sexual and Gender Minority Research Office.

NOSI: Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars
(NOT-OD-23-031)
Submission dates vary by awarding Institute or Center.

NOSI: Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards
(NOT-OD-23-032)
Submission dates vary by awarding Institute or Center.

NOSI: Priority Research Opportunities in Crisis Response Services
(NOT-MH-23-140)
First Available Due Date: February 5, 2023; additional submission dates vary by awarding Institute or Center.

NOSI: Implementation Science to Advance Maternal Health and Maternal Health Equity for the IMPROVE Initiative
(NOT-HD-22-043)
Application due date: February 6, 2023

NOSI: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional)
(NOT-OD-23-018)
Application due date: February 17, 2023

Team Science Leadership Scholars Program (LSP) in Women’s Health, Autoimmune and Immune-Mediated Diseases
(RFA-AMPAIM-LSP-22-001)
Application due date: February 20, 2023

Planning for the TMD Collaborative for IMproving PAtient-Centered Translational Research (TMD IMPACT) (R34 Clinical Trial Not Allowed)
(RFA-DE-23-014)
Application due date: April 14, 2023

Enhancing the Use of the All of Us Research Program’s Data (R21 Clinical Trial Not Allowed)
(RFA-PM-23-001)
Application due date: March 1, 2023

Additional Funding Opportunities